Top-News
Sonstige USA

OraSure Tech News

Aktie
WKN:  881351 ISIN:  US68554V1089 US-Symbol:  OSUR
4,40 €
+0,02 €
+0,46%
29.05.24 15:31:22
Handeln Depot/Watchlist
Aktienanzahl *
73,48 Mio.
Marktkapitalisierung *
320,36 Mio. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 26.02.2024

OraSure Tech News

01.06.23 - PR Newswire
Thinking about buying stock in OraSure Technologies, Quipt Home Medical, Talkspace, Frontline, or Oncolytics Biotech?
Thinking about buying stock in OraSure Technologies, Quipt Home Medical, Talkspace, Frontline, or Oncolytics Biotech? PR Newswire
15.02.23 - PR Newswire
Thinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox?
Thinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox? PR Newswire
28.09.22 - PR Newswire
Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies?
Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies? PR Newswire
25.01.22 - GlobeNewswire
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) --  OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-​of-care and home diagnostic testing and sample ...
04.10.21 - PR Newswire
Thinking about buying stock in OpGen, Adverum Biotechnologies, OraSure Technologies, Sonnet BioTherapeutics, or Sio Gene Therapies?
Thinking about buying stock in OpGen, Adverum Biotechnologies, OraSure Technologies, Sonnet BioTherapeutics, or Sio Gene Therapies? PR Newswire
09.11.20 - PR Newswire
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers
Clinical Reference Laboratory to Market Most Cost-​Effective, Gold-​Standard Self-​Collected COVID-19 Saliva Test Directly to Consumers Highly Accurate CRL Rapid Response™ Saliva ...
04.09.20 - PR Newswire
Thinking about buying stock in OraSure Technologies, FuelCell Energy, Norwegian Cruise Line, Zynga Inc, or Nio Inc?
Thinking about buying stock in OraSure Technologies, FuelCell Energy, Norwegian Cruise Line, Zynga Inc, or Nio Inc? PR Newswire
17.06.20 - PR Newswire
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-​Temperature Microbiome Sampling Solution for Metabolomics OMNImet™·GUT expands access to critical ...
22.05.20 - PR Newswire
Thinking about trading stocks or options in Burlington Stores, Floor & Decor Holdings, Sea Ltd, OraSure Technologies, or American Airlines Group?
Thinking about trading stocks or options in Burlington Stores, Floor & Decor Holdings, Sea Ltd, OraSure Technologies, or American Airlines Group? PR Newswire
11.05.20 - PR Newswire
Thinking about buying stock in AMC Entertainment, Carnival Corp, OraSure Technologies, Inovio Pharmaceuticals, or Aytu Bioscience?
Thinking about buying stock in AMC Entertainment, Carnival Corp, OraSure Technologies, Inovio Pharmaceuticals, or Aytu Bioscience? PR Newswire
17.12.19 - PR Newswire
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test PR Newswire
08.05.19 - PR Newswire
CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market
CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market PR Newswire
15.10.13 - PR Newswire
The Latino Commission on AIDS Joins with Actress/Model Dayana Mendoza to Promote HIV Testing for National Latino AIDS Awareness Day
The Latino Commission on AIDS Joins with Actress/Model Dayana Mendoza to Promote HIV Testing for National Latino AIDS Awareness Day PR Newswire
25.03.13 - PR Newswire
OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status
OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status Earvin "Magic" Johnson Helps Kick Off Awareness ...
21.12.12 - Aktiencheck
OraSure Technologies-Aktie: "buy" - Mizuho Securities USA
Die Analysten von Mizuho Securities USA stufen die OraSure Technologies-​Aktie in einer Ersteinschätzung mit "buy" ein. Das Kursziel werde bei 9 USD gesehen. (Analyse vom ...
13.09.12 - Aktiencheck
OraSure Technologies-Aktie: "buy" - ThinkEquity Partners
Spencer Nam und Mary Nielson, Analysten von ThinkEquity Partners, bewerten die OraSure Technologies-​Aktie weiterhin mit dem Rating "buy". Das Kursziel werde bei 17 USD ...
09.08.12 - Aktiencheck
OraSure Technologies-Aktie: "outperform" - Barrington Research
Charley R. Jones, Analyst von Barrington Research, stuft die Aktie von OraSure Technologies auf "outperform" hoch. Das Kursziel werde bei 12,50 USD gesehen. (Analyse vom ...
06.07.12 - Aktiencheck
OraSure Technologies-Aktie: "buy" - Canaccord Genuity
Jeffrey Frelick und Mark Massaro, Analysten von Canaccord Genuity, stufen die Aktie von OraSure Technologies weiterhin mit "buy" ein. Das Kursziel sehe man unverändert bei 14 ...
06.07.12 - Aktiencheck
OraSure Technologies-Aktie: Herabstufung - Barrington Research
Charley R. Jones, Analyst von Barrington Research, stuft die Aktie von OraSure Technologies von "outperform" auf "market perform" herab. (Analyse vom 05.07.2012) ...
04.07.12 - Der Aktionär
Orasure Technologies: Neuer HIV-Test katapultiert Aktie nach oben

Newssuche

Videos

29.05.24 +24,01%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »